Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.

Starrenburg FC, Bogers JP.

Eur Psychiatry. 2009 Apr;24(3):164-70. doi: 10.1016/j.eurpsy.2009.01.001. Epub 2009 Mar 14. Review.

PMID:
19285836
2.

The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.

Assié MB, Carilla-Durand E, Bardin L, Maraval M, Aliaga M, Malfètes N, Barbara M, Newman-Tancredi A.

Eur J Pharmacol. 2008 Sep 11;592(1-3):160-6. doi: 10.1016/j.ejphar.2008.06.105. Epub 2008 Jul 4.

PMID:
18640111
3.

Metabolic effects of the atypical antipsychotics.

Wooten J.

South Med J. 2007 Aug;100(8):771-2. Review. No abstract available.

PMID:
17713300
4.

Atypical antipsychotics and diabetes mellitus.

Schwenkreis P, Assion HJ.

World J Biol Psychiatry. 2004 Apr;5(2):73-82. Review.

PMID:
15179666
5.
6.

Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.

Montastruc F, Palmaro A, Bagheri H, Schmitt L, Montastruc JL, Lapeyre-Mestre M.

Eur Neuropsychopharmacol. 2015 Oct;25(10):1556-65. doi: 10.1016/j.euroneuro.2015.07.010. Epub 2015 Jul 21.

PMID:
26256010
7.

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model.

Hahn M, Chintoh A, Giacca A, Xu L, Lam L, Mann S, Fletcher P, Guenette M, Cohn T, Wolever T, Arenovich T, Remington G.

Schizophr Res. 2011 Sep;131(1-3):90-5. doi: 10.1016/j.schres.2011.06.004. Epub 2011 Jun 22.

PMID:
21696923
8.

Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.

Bruins Slot LA, De Vries L, Newman-Tancredi A, Cussac D.

Eur J Pharmacol. 2006 Mar 18;534(1-3):63-70. Epub 2006 Feb 21.

PMID:
16497294
9.

A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.

Citrome L, Kalsekar I, Baker RA, Hebden T.

Curr Med Res Opin. 2014 Aug;30(8):1629-41. doi: 10.1185/03007995.2014.908280. Epub 2014 May 19. Review.

PMID:
24666104
10.

Receptor reserve-dependent properties of antipsychotics at human dopamine D2 receptors.

Tadori Y, Forbes RA, McQuade RD, Kikuchi T.

Eur J Pharmacol. 2009 Apr 1;607(1-3):35-40. doi: 10.1016/j.ejphar.2009.02.007. Epub 2009 Feb 13.

PMID:
19217900
11.

[Expectations and developments in atypical antipsychotics].

[No authors listed]

Praxis (Bern 1994). 2004 Aug 25;93(35):1392. German. No abstract available.

PMID:
15468579
12.

Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.

Auclair AL, Kleven MS, Barret-Grévoz C, Barreto M, Newman-Tancredi A, Depoortère R.

Behav Brain Res. 2009 Nov 5;203(2):288-95. doi: 10.1016/j.bbr.2009.05.015. Epub 2009 May 21.

PMID:
19464324
13.

Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.

Heusler P, Newman-Tancredi A, Loock T, Cussac D.

Eur J Pharmacol. 2008 Feb 26;581(1-2):37-46. doi: 10.1016/j.ejphar.2007.11.046. Epub 2007 Nov 28.

PMID:
18190908
14.

Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.

Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Mistry Kannan T, Molski TF, Yocca FD, Sharp T, Kikuchi T, Burris KD.

Psychopharmacology (Berl). 2007 Feb;190(3):373-82. Epub 2006 Nov 25.

PMID:
17242925
15.

Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

Teff KL, Kim SF.

Physiol Behav. 2011 Sep 26;104(4):590-8. doi: 10.1016/j.physbeh.2011.05.033. Epub 2011 Jun 12. Review.

16.

Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.

Cohen D, Correll CU.

J Clin Psychiatry. 2009 May;70(5):765-6. No abstract available.

PMID:
19552870
18.

Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.

Wood MD, Scott C, Clarke K, Cato KJ, Patel N, Heath J, Worby A, Gordon L, Campbell L, Riley G, Davies CH, Gribble A, Jones DN.

CNS Neurol Disord Drug Targets. 2006 Aug;5(4):445-52.

PMID:
16918396
19.
20.

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.

J Clin Psychiatry. 2004;65 Suppl 18:47-56.

Supplemental Content

Support Center